On this episode of Stock Movers:
- GSK raised its profit and sales forecasts for the year, aided by its HIV and immunology medicines, in Emma Walmsley’s last report as CEO. 
- Mercedes-Benz Group confirmed its annual outlook and plans to proceed with a €2 billion share buyback after the company’s margin climbed in 3Q.
- Equinor said 3Q earnings slumped as oil prices softened and trading profits declined, its adjusted operating income after tax fell by about a quarter to $1.51 billion, missing the average analyst estimate.

On this episode of Stock Movers: - GSK raised its profit and sales forecasts for the year, aided by its HIV and immunology medicines, in Emma Walmsley&rsquo;s last report as CEO. - Mercedes-Benz Group confirmed its annual outlook and plans to proceed with a &euro;2 billion share buyback after the company&rsquo;s margin climbed in 3Q. - Equinor said 3Q earnings slumped as oil prices softened and trading profits declined, its adjusted operating income after tax fell by about a quarter to $1.51 billion, missing the average analyst estimate.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

GSK Up, Mercedes Soars, Equinor Slips

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/0319c95d-fadd-4a3d-977f-b38500955924/transcript

Advertisement